Form D · REITS and Finance

Flagship Healthcare Trust, Inc.

Charlotte, NC · CIK 0001730261

Offering snapshot reported May 22, 2026 · SEC filing

Reported sold
$95.1M
Offering amount: $500M
Investors reported
204
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 21, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$47.5M$95.1MApr 5, 2018: $1,000,000.00Apr 5, 2018Apr 3, 2019: $4,996,369.00May 23, 2025: $84,451,451.00May 22, 2026: $95,060,171.00May 22, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$84,451,451 → $95,060,171
  • Reported investors272 → 204

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 22, 2026Amendment$95,060,171$10,608,720vs May 23, 2025204SEC filing
May 23, 2025Amendment$84,451,451$79,455,082vs Apr 3, 2019272SEC filing
Apr 3, 2019Amendment$4,996,369$3,996,369vs Apr 5, 2018135SEC filing
Apr 5, 2018Initial$1,000,000No comparison3SEC filing
Feb 5, 2018Initial$56,050,025No comparison97SEC filing

Offering details

Securities
Equity, Pooled investment fund
Exemptions
3C, 3C.1, 3C.5, 3C.7
Duration over one year
Yes
Business combination
No
Sales commissions
$326K
Finders' fees
$0
Form D file number
021-309437
Includes $82,110,271 of securities sold pursuant to a prior Rule 506(b) offering. The total number of investors in this Form D amendment is lower than reported in the 2025 Form D to account for an administrative reporting error in that filing.
The amount paid to the recipient reflects compensation associated with his registrations with both his current and former broker-dealers during the relevant periods.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Jeffrey Scott Spray2100346FNEX CAPITAL, LLC · CRD 166316

Source: Form D, filed May 22, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
M. Hunt Broyhill Director
W. Charles Campbell Director, Executive
Bradley H. Carroll Director
J. Brannen Edge Iii Director, Executive
Theresa Gebhardt Director
Nelson Schwab Iii Director
Kyle Sweeney Director, Executive
William K. Tate, Iii Executive
William K. Tate, I Il Executive

Issuer details

Industry: REITS and Finance (See others in industry)

Address:
2701 Coltsgate Road, Suite 300
Charlotte, NC, 28211